News

Filter

Current filters:

None

Popular Filters

7951 to 7975 of 8856 results

TaiGen gets global nemonoxacin rights

11-12-2011

Taiwan’s TaiGen Biotechnology has reached a deal with Ireland-headquartered Warner Chilcott (Nasdaq:…

Antibiotics and Infectious diseasesBiotechnologyLicensingnemonoxacinPharmaceuticalTaiGen BiotecnologyWarner Chilcott

GMiA welcomes TGA blueprint for reform

11-12-2011

Australia’s Generic Medicines Industry Association (GMiA) says it welcomes the release last week…

Asia-PacificGenericsPoliticsRegulation

EUnetHTA position paper developed

11-12-2011

The European Network for Health Technology Assessment (EUnetHTA) Joint Action Conference in Gdansk, Poland,…

BiotechnologyEuropeRegulation

J&J to pay nearly $1 billion for cancer drug candidate

09-12-2011

US health care giant Johnson & Johnson (NYSE: JNJ), through its subsidiary Janssen Biotech, has executed…

Janssen BiotechJohnson & JohnsonLicensingOncologyPharmaceuticalPharmacyclics

Pfizer’s axitinib favored by FDA panel

09-12-2011

Global drugs behemoth Pfizer (NYSE: PFE) says that the U.S. Food and Drug Administration’s Oncologic…

axitinibNorth AmericaOncologyPfizerPharmaceuticalRegulation

FDA committee backs Affymax CKD drug

09-12-2011

The US Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC) voted 15 to one,…

AffymaxNephrology and HepatologyNorth AmericaOncologypeginesatidePharmaceuticalRegulationTakeda Pharmaceuticals

Mixed views on drospirenone OCs

09-12-2011

The majority of members of the US Food and Drug Administration’s Reproductive Health Drugs Advisory…

BayerDrospirenone and EstradiolNorth AmericaPharmaceuticalRegulationReproductiveWomen's HealthYasminYaz

Overactive bladder gel gets FDA nod

09-12-2011

The US Food and Drug Administration (FDA) has approved US drugmaker Antares Pharma’s (NYSE Amex:…

Antares PharmaGenito-urinaryNorth AmericaOxybutyninPharmaceuticalRegulationWatson Pharmaceuticals

Breast cancer therapy news at SABCS

09-12-2011

This year’s CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) in Texas, USA, heard of developments…

AfinitorGenerex BiotechnologyNovartisOncologypertuzumabPharmaceuticalResearchRoche

FDA reviews Pradaxa bleeding risk

08-12-2011

Post-marketing reports of serious bleeding events in patients taking Pradaxa (dabigatran etexilate mesylate),…

Boehringer IngelheimCardio-vascularNorth AmericaPharmaceuticalPradaxaRegulation

Australia to improve therapeutics regulation

08-12-2011

The Australian government said yesterday that it will introduce a comprehensive package of reforms for…

Asia-PacificMarkets & MarketingPharmaceuticalRegulation

Sinclair IS buys derma company

08-12-2011

UK specialty drugmaker Sinclair IS Pharma plc (AIM: SPH.L) has entered into an agreement to acquire USA-based…

Advanced Bio-TechnologiesDermatologicalsKelo-coteMergers & AcquisitionsPharmaceuticalSinclair IS Pharma

MAbs largest class of biotherapeutics

08-12-2011

Monoclonal antibodies (MAbs) were the fastest growing segment in the global pharmaceutical market in…

BiotechnologyMarkets & Marketing

Chinese pharma growth forecasts

08-12-2011

Sustained double-digit growth in the Chinese pharmaceutical market from 2011 is forecast by UK-based…

Asia-PacificMarkets & MarketingPharmaceutical

AstraZeneca expands in China, cuts back in USA

08-12-2011

It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

FDA plans biosimilars user fee talks

08-12-2011

The US Food and Drug Administration has published a Federal Register notice announcing a December 16…

BiotechnologyFinancialGenericsNorth AmericaRegulation

NICE wants more data on Daxas

08-12-2011

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has today issued final…

DaxasEuropeMerck & CoPharmaceuticalPricingRegulationRespiratory and Pulmonary

Dendreon cashes in Victrelis royalty

08-12-2011

US pharma company Dendreon (Nasdaq: DNDN) says that it has agreed to sell for $125 million in cash its…

Anti-viralsBiotechnologyDendreonFinancialLicensingMerck & CoOncologyPharmaceuticalProvengeVictrelis

Theratechnologies to quit COPD program

08-12-2011

Canada-based Theratechnologies (TSX: TH.TO) revealed yesterday that it is discontinuing its muscle wasting…

EgriftaFinancialNephrology and HepatologyPharmaceuticalResearchRespiratory and PulmonarytesamorelinTheratechnologies

Voraxaze out-licensed in Japan

07-12-2011

UK health care firm BTG (LSE: BGC) says that it has licensed the Japanese rights to glucarpidase (which…

Asia-PacificBTGglucarpidaseLicensingOhara PharmaceuticalOncologyPharmaceuticalVoraxaze

Diabetes Rxing in China and S Korea

07-12-2011

Dipeptidyl peptidase IV (DPP-IV) inhibitors are prescribed more commonly for the treatment of type 2…

Asia-PacificDiabetesGalvusJanuviaMarkets & MarketingMerck & CoNovartisPharmaceuticalPricing

EMA and EFPIA debate modelling

07-12-2011

Modelling and simulation methodology provides an opportunity to improve the efficiency of pharmaceutical…

EuropePharmaceuticalRegulationResearch

China to strengthen drug safety

07-12-2011

China’s State Council (Cabinet) this week approved a blueprint to establish a credit rating system…

Asia-PacificHealthcarePharmaceuticalRegulation

7951 to 7975 of 8856 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top